Freeze-drying of composite core-shell nanoparticles

Drug Development and Industrial Pharmacy

Volumn 32, Issue 7, 2006, Pages 839-846

  Layre, A M ^a   Couvreur, P ^a   Richard, J ^b,c   Requier, D ^b   Ghermani, N Eddine ^a   Gref, R ^a  

^a UNIV PARIS SUD   (France)

^b Ethypharm   (France)

^c NONE   (Italy)

Author keywords

Freeze drying; Nanoparticle composites; PCL PEG; PIBCA

Indexed keywords

GLUCOSE; MACROGOL; MALTOSE; NANOPARTICLE; POLOXAMER; POLY(ISOBUTYL 2 CYANOACRYLATE); POLYCAPROLACTONE; SUCROSE; SURFACTANT; TREHALOSE;

ARTICLE; DISPERSION; FREEZE DRYING; HYDROPHILICITY; HYDROPHOBICITY; PARTICLE SIZE; PRECIPITATION; SUSPENSION; ZETA POTENTIAL;

CYANOACRYLATES; DRUG COMPOUNDING; DRUG STABILITY; ETHYLENE OXIDE; FREEZE DRYING; GLUCOSE; LACTONES; MALTOSE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; POLOXAMER; POLYMERS; SUCROSE; SURFACE-ACTIVE AGENTS; SUSPENSIONS; TREHALOSE;

EID: 33747619131     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600685134     Document Type: Article

References (24)

1. Allemann, E., Leroux, J. C., & Gurny, R. (1998). Biodegradable nanoparticles of poly(lactic acid) and poly(lactic-co-glycolic acid) for parenteral administration. In Pharmaceutical Dosage Forms: Disperse Systems. Lieberman, H. A., Rieger, M. M., Bankers, G. S., Eds. New York: Marcel Dekker, 163-193.
2. Allemann, E., Leroux, J. C., Gurny, R., & Doelker, E. (1993). In vitro extended-release properties of drug-loaded poly(DL-lactic acid) nanoparticles produced by a salting-out procedure. Pharm Res, 10, 1732-1737.
3. Alonso, M. J. (1995). Nanoparticulate drug carrier technology. In Microparticulate System for the Delivery of Proteins and Vaccines. Cohen, S., Bernstein, H., Eds. New York: Marcel Dekker, 203-242.
4. Bala, I., Hariharan, S., & Kumar, M. (2004). PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst, 21(5), 387-422.
5. Chacon, M., Molpeceres, J., Berges, L., Guzman, M., & Aberturas, M. R. (1999). Stability and freeze-drying of cyclosporine loaded poly(DL, lactide-glycolide) carriers. Eur J Pharm Sci, 8(2), 99-107.
6. Couvreur, P., Dubernet, C., & Puisieux, F. (1995). Controlled drug delivery with nanoparticles: current possibilities and future trends. Eur J Pharm Biopharm, 41(1), 2-13.
7. De Jaeghere, F., Allemann, E., Feijen, J., Kissel, T., Doelker, E., & Gurny, R. (2000). Freeze-drying and lyopreservation of diblock and triblock poly(lactic acid)-poly(ethylene oxide) (PLA-PEO) copolymer nanoparticles. Pharm Dev Technol, 5(4), 473-483.
8. De Jaeghere, F., Allemann, E., Leroux, J. C., Stevels, W., Feijen, J., Doelker, E., & Gurny, R. (1999). Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake. Pharm Res, 16(6), 859-866.
9. Fessi, H. C., & Devissaguet, J. P. (1992). Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles. US 5,118,528, June 2.
10. Floyd, A. G. (1999). Top ten considerations in the development of parenteral emulsions. Pharm Sci Technol Today, 4(2), 134-143.
11. Gref, R. (2003). Surface engineered nanoparticles as drug carriers. In Synthesis, Functionalization and Surface Treatment of Nanoparticles. Baraton, M.-I., Ed., Los Angeles: American Scientific Publishers, 233-256.
12. Gref, R., Luck, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Muller, R. H. (2000). Stealth corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces, 18(3-4), 301-313.
13. Grochow, L. B., Jones, R. J., Brundrett, R. B., Braine, H. G., Chen, T. L., Saral, R., Santos, G. W., & Colvin, O. (1989). M. Pharmacokinetics of busulfan: correlation with veino-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol, 25(1), 55-61.
14. Hassan, M., Oberg, G., Bekassy, A. N., Aschan, J., Ehrsson, H., Ljungman, P., Lonnerholm, G., Smedmyr, B., Taube, A., Wallin, I., & et al. (1991). Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology. Cancer Chemother Pharmacol, 28(2), 130-134.
15. Izutsu, K., Yoshioka, S., Kojima, S., Randolph, T. W., & Carpenter, J. F. (1996). Effects of sugars and polymers on crystallization of poly(ethylene glycol) in frozen solutions: phase separation between incompatible polymers. Pharm Res, 13(9), 1393-1400.
16. Konan, Y. N., Gurny, R., & Allemann, E. (2002). Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int J Pharm, 233(1-2), 239-252.
17. Kreuter, J. (1983). Evaluation of nanoparticles as drug-delivery system III: materials, stability, toxicity, possibilities of targeting, and use. Pharm Acta Helv, 58, 196-209.
18. Layre, A., Couvreur, P., Chacun, H., Richard, J., Passirani, C., Requier, D., Benoit, J. P., Gref, R. (2006). Novel composite core-shell nanoparticles as busulfan carriers. J Cont Rel, 111, 271-280.
19. Layre, A., Gref, R., Couvreur, P., Richard, J. (2004). Nanoparticules polymériques composites. FR 2 872 703, 7 July 2004.
20. Lemoine, D., Francois, C., Kedzierewicz, F., Preat, V., Hoffman, M., Maincent, P. (1990). Stability study of nanoparticles of poly(ecaprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide). Biomaterials, 17(22), 2191-2197.
21. Mainardes, R., & Silva, L. (2004). Drug delivery systems: past, present, and future. Curr Drug Targets, 5(5), 449-455.
22. Quintanar-Guerrero, D., Ganem-Quintanar, A., Allemann, E., Fessi, H., & Doelker, E. (1998). Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique. J Microencapsul, 15(1), 107-119.
23. Saez, A., Guzman, M., Molpeceres, J., & Aberturas, M. R. (2000). Freeze-drying of polycaprolactone and poly(DL-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. Eur J Pharm Biopharm, 50(3), 379-387.
24. Zambaux, M. F., Bonneaux, F., Gref, R., Dellacherie, E., & Vigneron, C. (1999). MPEO-PLA nanoparticles: effect of MPEO content on some of their surface properties. J Biomed Mater Res, 44(1), 109-115.